Fiasp and Fludeoxyglucose f 18 Intravenous

In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.

Insulin aspart may affect the diagnostic results of fludeoxyglucose F-18. Talk to your doctor before you are scheduled for testing to find out if and for how long you should stop using insulin aspart so that it does not interfere with fludeoxyglucose F-18 test results. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

MONITOR: Certain medications may interfere with the results of diagnostic studies using fludeoxyglucose F18 by increasing or decreasing uptake of the agent into tissues.

MANAGEMENT: Clinicians should be aware of possible diagnostic interference associated with the following medications: colony-stimulating factors may increase uptake in spleen and bone marrow; glucose-induced hyperglycemia may interfere with uptake; dopamine and insulin may decrease myocardial and tumor cell uptake; laxative-induced intestinal muscle activity and/or irritation may increase intestinal uptake.

Fiasp

Generic Name: insulin aspart

Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch

Synonyms: Fiasp Injection

What is Fiasp?

Fludeoxyglucose f 18 Intravenous

Generic Name: fludeoxyglucose f18

Brand name:

Synonyms: Fludeoxyglucose F 18

What is Fludeoxyglucose f 18 Intravenous?